JP2024508347A5 - - Google Patents
Info
- Publication number
- JP2024508347A5 JP2024508347A5 JP2023537357A JP2023537357A JP2024508347A5 JP 2024508347 A5 JP2024508347 A5 JP 2024508347A5 JP 2023537357 A JP2023537357 A JP 2023537357A JP 2023537357 A JP2023537357 A JP 2023537357A JP 2024508347 A5 JP2024508347 A5 JP 2024508347A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- sulfur
- nitrogen
- oxygen
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063128680P | 2020-12-21 | 2020-12-21 | |
| US63/128,680 | 2020-12-21 | ||
| US202163223971P | 2021-07-20 | 2021-07-20 | |
| US63/223,971 | 2021-07-20 | ||
| US202163287390P | 2021-12-08 | 2021-12-08 | |
| US63/287,390 | 2021-12-08 | ||
| PCT/US2021/064339 WO2022140252A1 (en) | 2020-12-21 | 2021-12-20 | Nanomaterials comprising ester-linked acetals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508347A JP2024508347A (ja) | 2024-02-27 |
| JP2024508347A5 true JP2024508347A5 (cg-RX-API-DMAC10.html) | 2024-12-27 |
Family
ID=82159839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537357A Pending JP2024508347A (ja) | 2020-12-21 | 2021-12-20 | エステル結合アセタールを含むナノ材料 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230331657A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4262819A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024508347A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230133986A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021410666A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3203295A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL303365A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023007137A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022140252A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7600208B2 (ja) | 2019-07-29 | 2024-12-16 | ジョージア テック リサーチ コーポレイション | 拘束された脂質を含むナノ材料およびその使用 |
| CN115175894B (zh) | 2020-01-09 | 2024-09-06 | 盖德治疗有限责任公司 | 纳米材料 |
| EP4262817A4 (en) * | 2020-12-21 | 2025-03-12 | Beam Therapeutics Inc. | NANOMATERIALS WITH ACETALS |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| US20230263742A1 (en) * | 2021-05-06 | 2023-08-24 | Stemirna Therapeutics Co., Ltd. | A lipid |
| WO2023044343A1 (en) * | 2021-09-14 | 2023-03-23 | Renagade Therapeutics Management Inc. | Acyclic lipids and methods of use thereof |
| TW202328067A (zh) | 2021-09-14 | 2023-07-16 | 美商雷納嘉德醫療管理公司 | 環狀脂質及其使用方法 |
| WO2023081526A1 (en) | 2021-11-08 | 2023-05-11 | Orna Therapeutics, Inc. | Lipid nanoparticle compositions for delivering circular polynucleotides |
| WO2023121965A1 (en) * | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterial comprising diamines |
| WO2023122752A1 (en) | 2021-12-23 | 2023-06-29 | Renagade Therapeutics Management Inc. | Constrained lipids and methods of use thereof |
| WO2023138611A1 (en) * | 2022-01-19 | 2023-07-27 | Suzhou Abogen Biosciences Co., Ltd. | Lipid compounds and lipid nanoparticle compositions |
| EP4540222A1 (en) | 2022-07-20 | 2025-04-23 | Beam Therapeutics Inc. | Nanomaterials comprising triols |
| JP2025540623A (ja) | 2022-11-11 | 2025-12-16 | ビーム セラピューティクス インク. | トランスサイレチン遺伝子の塩基編集 |
| WO2024112775A1 (en) * | 2022-11-25 | 2024-05-30 | Beam Therapeutics Inc. | Compositions and methods for editing a transthyretin gene |
| CN120418427A (zh) | 2022-12-23 | 2025-08-01 | 因特利亚治疗公司 | 用于基因组编辑的系统和方法 |
| CN118108613B (zh) * | 2022-12-26 | 2025-05-06 | 北京新合睿恩生物医疗科技有限公司 | 一种阳离子脂质化合物及制备方法和应用、mRNA递送系统 |
| WO2024192291A1 (en) * | 2023-03-15 | 2024-09-19 | Renagade Therapeutics Management Inc. | Delivery of gene editing systems and methods of use thereof |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025000542A1 (en) * | 2023-06-30 | 2025-01-02 | Shanghai Vitalgen Biopharma Co., Ltd. | Ionizable cationic lipid compounds for delivery of biologically active agents |
| TW202517607A (zh) * | 2023-07-19 | 2025-05-01 | 香港商正基基因科技有限公司 | 脂質和脂質奈米顆粒 |
| EP4762030A1 (en) * | 2023-08-16 | 2026-06-24 | Beam Therapeutics Inc. | Ionizable lipids with branched head groups |
| WO2025159966A1 (en) * | 2024-01-23 | 2025-07-31 | Beam Therapeutics Inc. | Compositions and methods for altering a nucleobase in a transthyretin polynucleotide |
| WO2025212851A2 (en) | 2024-04-03 | 2025-10-09 | Orbital Therapeutics, Inc. | mRNA COMPOSITIONS AND USES THEREOF IN VARICELLA ZOSTER VIRUS VACCINES |
| WO2025259931A1 (en) | 2024-06-14 | 2025-12-18 | Orbital Therapeutics, Inc. | Compositions and methods for rna circularization |
| WO2026006203A2 (en) | 2024-06-24 | 2026-01-02 | Orbital Therapeutics, Inc. | Compositions and methods for making circular rna |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026006687A1 (en) | 2024-06-28 | 2026-01-02 | Orbital Therapeutics, Inc. | Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus |
| WO2026096539A1 (en) | 2024-10-28 | 2026-05-07 | Beam Therapeutics Inc. | Secondary alcohol lipids |
| WO2026126136A1 (en) * | 2024-12-11 | 2026-06-18 | Helex Inc. | Novel acetal oxolane lipids |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2075970B (en) * | 1980-04-10 | 1984-05-02 | Nippon Paint Co Ltd | Polymerisable amino acid compounds and their production |
| EP1021549A2 (en) | 1997-09-19 | 2000-07-26 | Sequitur, Inc. | SENSE mRNA THERAPY |
| DE19940641A1 (de) * | 1999-08-26 | 2001-03-01 | Basf Ag | Verfahren zur Herstellung von 4-Acyl-aminosäureestern und N-Acyl-Aminoacetalen |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| HRP20220156T1 (hr) | 2015-09-17 | 2022-04-15 | Modernatx, Inc. | Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| MX2019009070A (es) * | 2017-02-01 | 2019-10-30 | Modernatx Inc | Composiciones de arnm terapeuticas inmunomoduladoras que codifican peptidos de mutacion de oncogenes de activacion. |
| MX2021003455A (es) * | 2018-10-02 | 2021-09-21 | Intellia Therapeutics Inc | Lípidos con amina ionizables. |
| WO2020219876A1 (en) * | 2019-04-25 | 2020-10-29 | Intellia Therapeutics, Inc. | Ionizable amine lipids and lipid nanoparticles |
| CN115175894B (zh) * | 2020-01-09 | 2024-09-06 | 盖德治疗有限责任公司 | 纳米材料 |
| AU2021269137A1 (en) * | 2020-05-08 | 2022-12-15 | Orna Therapeutics, Inc. | Circular RNA compositions and methods |
-
2021
- 2021-12-20 JP JP2023537357A patent/JP2024508347A/ja active Pending
- 2021-12-20 MX MX2023007137A patent/MX2023007137A/es unknown
- 2021-12-20 AU AU2021410666A patent/AU2021410666A1/en active Pending
- 2021-12-20 CA CA3203295A patent/CA3203295A1/en active Pending
- 2021-12-20 WO PCT/US2021/064339 patent/WO2022140252A1/en not_active Ceased
- 2021-12-20 IL IL303365A patent/IL303365A/en unknown
- 2021-12-20 EP EP21911970.8A patent/EP4262819A4/en active Pending
- 2021-12-20 KR KR1020237023906A patent/KR20230133986A/ko active Pending
-
2023
- 2023-06-20 US US18/211,857 patent/US20230331657A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024503976A5 (cg-RX-API-DMAC10.html) | ||
| TWI789695B (zh) | 治療sars cov-2感染之方法 | |
| JP2024505449A5 (cg-RX-API-DMAC10.html) | ||
| JP2025501731A5 (cg-RX-API-DMAC10.html) | ||
| JP2024503441A5 (cg-RX-API-DMAC10.html) | ||
| TWI715944B (zh) | 治療性化合物 | |
| JP2024502948A5 (cg-RX-API-DMAC10.html) | ||
| JP2024542755A5 (cg-RX-API-DMAC10.html) | ||
| TWI878811B (zh) | 用於治療病毒感染的化合物及方法 | |
| KR20220164784A (ko) | 1'-시아노 치환된 카르바뉴클레오시드 유사체의 흡입 제형 | |
| JP2024542541A5 (cg-RX-API-DMAC10.html) | ||
| JP2024502954A5 (cg-RX-API-DMAC10.html) | ||
| TW202400185A (zh) | 用於治療病毒感染的化合物及方法 | |
| WO2017190145A1 (en) | Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis | |
| JP2021102643A5 (cg-RX-API-DMAC10.html) | ||
| JP7832717B2 (ja) | 硫化物を含むイオン化可能な脂質、及びこれを含む脂質ナノ粒子 | |
| JP2018138570A (ja) | 癌の治療のためのamg900の使用 | |
| WO2025146125A1 (zh) | 用于递送的脂质化合物和脂质纳米颗粒 | |
| CN117430541A (zh) | 用于向细胞递送的化合物及其组合物 | |
| CN102058574A (zh) | 富马酸衍生物在治疗心功能不全中的应用 | |
| KR20250164231A (ko) | 작용제의 전달을 위한 지질 나노입자 | |
| EP4346772B1 (en) | Phospholipid formulations of 1'-cyano substituted carba-nucleoside analogs | |
| JP6469727B2 (ja) | 線維症の抑制又は治療方法 | |
| JP2003527414A (ja) | C型肝炎を治療するための薬剤 | |
| WO2024220742A9 (en) | Conjugated polyethyleneimine compounds and compositions, and uses thereof for the treatment of atherosclerosis, cardiovascular, and lung disease |